Eva von Schoultz

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi Menopausal hormone therapy after breast cancer: the Stockholm randomized trial
    Eva von Schoultz
    Department of Oncology, Karolinska University Hospital and Institute, Stockholm, Sweden
    J Natl Cancer Inst 97:533-5. 2005
  2. ncbi Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours
    Hans Jacobsson
    Department of Radiology, Karolinska University Hospital, Stockholm, Sweden
    Nucl Med Commun 27:347-52. 2006
  3. doi Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women
    Marie Hofling
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Gynecol Endocrinol 24:405-10. 2008
  4. doi Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
    Mia Fahlén
    Department of Surgery, Capio St Görans Hospital, Stockholm, Sweden
    Eur J Cancer 49:52-9. 2013
  5. ncbi Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study
    Eva Lundström
    Department of Obstetrics and Gynecology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 85:989-95. 2006
  6. ncbi [Can serum estradiol predict the effect of raloxifene on breast cancer risk?]
    Eva von Schoultz
    Bröstenheten, Radiumhemmet, Karolinska sjukhuset, Stockholm
    Lakartidningen 99:2068. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Menopausal hormone therapy after breast cancer: the Stockholm randomized trial
    Eva von Schoultz
    Department of Oncology, Karolinska University Hospital and Institute, Stockholm, Sweden
    J Natl Cancer Inst 97:533-5. 2005
    ..Doses of estrogen and progestogen and treatment regimens for menopausal hormone therapy may be associated with the recurrence of breast cancer...
  2. ncbi Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours
    Hans Jacobsson
    Department of Radiology, Karolinska University Hospital, Stockholm, Sweden
    Nucl Med Commun 27:347-52. 2006
    ..For this purpose, we employed a patient cohort from a previous study assessing the response to neoadjuvant chemotherapy for breast cancer using Tc-hexakis-2-methoxyisobutylisonitrile (Tc-sestamibi)...
  3. doi Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women
    Marie Hofling
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Gynecol Endocrinol 24:405-10. 2008
    ....
  4. doi Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
    Mia Fahlén
    Department of Surgery, Capio St Görans Hospital, Stockholm, Sweden
    Eur J Cancer 49:52-9. 2013
    ..Observational studies have suggested decreased recurrence rates from HRT. The few clinical trials in this field have all been closed preterm...
  5. ncbi Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study
    Eva Lundström
    Department of Obstetrics and Gynecology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 85:989-95. 2006
    ..To perform a pilot study of the effects on the breast by low-dose intrauterine progestogen combined with estrogen...
  6. ncbi [Can serum estradiol predict the effect of raloxifene on breast cancer risk?]
    Eva von Schoultz
    Bröstenheten, Radiumhemmet, Karolinska sjukhuset, Stockholm
    Lakartidningen 99:2068. 2002